TELIF (Telescope Innovations) Common Stock: $12.44 Mil (As of May. 2026)


TELIF Telescope Innovations Corp TELIF
27 GF Score
Price $0.53
GF Value $0.38
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Telescope Innovations Common Stock?

Telescope Innovations TELIF +3.14% 27 Common Stock is $12.44 Mil as of May. 2026. GuruFocus rates TELIF with a GF Score™ of 27/100 and a GF Value™ of $0.38 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Telescope Innovations's quarterly common stock increased from Nov. 2025 ($12.14 Mil) to Feb. 2026 ($12.51 Mil) but then declined from Feb. 2026 ($12.51 Mil) to May. 2026 ($12.44 Mil).

Telescope Innovations's annual common stock declined from Aug. 2023 ($7.67 Mil) to Aug. 2024 ($7.57 Mil) and declined from Aug. 2024 ($7.57 Mil) to Aug. 2025 ($7.50 Mil).

Telescope Innovations Common Stock Historical Data

* Premium members only.

The historical data trend for Telescope Innovations's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Telescope Innovations Common Stock Chart

Telescope Innovations Annual Data
Trend Dec19 Dec20 Aug21 Aug22 Aug23 Aug24 Aug25
Common Stock
Get a 7-Day Free Trial 6.43 6.93 7.67 7.57 7.50

Telescope Innovations Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.46 7.50 12.14 12.51 12.44
TELIF
27GF Score
Telescope Innovations Corp TELIF
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Telescope Innovations Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $12.44 Mil mean?
Telescope Innovations (TELIF) has a Common Stock of $12.44 Mil as of May. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Telescope Innovations and its competitors.
Is Telescope Innovations' Common Stock too high?
Telescope Innovations' current Common Stock is $12.44 Mil. Overall, Telescope Innovations has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Telescope Innovations' Common Stock compare to VRTX and REGN?
Telescope Innovations' Common Stock of $12.44 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Telescope Innovations and its competitors. Telescope Innovations's current Common Stock is $12.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telescope Innovations stock overvalued right now?
Based on GuruFocus' analysis, Telescope Innovations (TELIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.38, compared to a current price of $0.53 — trading 38.2% above its estimated fair value. The current Common Stock is $12.44 Mil. Telescope Innovations' overall GF Score™ is 27/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Telescope Innovations (TELIF), the current Common Stock is $12.44 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Telescope Innovations (TELIF) Overvalued in 2026?

Based on GuruFocus' analysis, Telescope Innovations stock appears to be overvalued. The current stock price of $0.53 is trading 38.2% above its estimated GF Value™ of $0.38. GuruFocus considers Telescope Innovations to be Significantly Overvalued.

Key valuation signals for TELIF:

  • Common Stock: $12.44 Mil
  • GF Value™: $0.38 vs. price of $0.53 (38.2% above fair value)
  • GF Score™: 27/100 with 1 warning sign

No single metric tells the full story. See the TELIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Telescope Innovations Business Description

Other Exchanges J4U:GermanyTELI:Canada
Address 2386 East Mall, Suite 301, Vancouver, BC, CAN, V6T 1Z3
Telescope Innovations Corp is a technology company focused on development as a Contract Research Organization (CRO) to develop intellectual property, provide contract research, and build automation products, and operates as a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. Its flagship product is the DirectInject-LC system. The Company operates in a single operating segment and generates revenue from three streams: contract research services, grant income, and the sale of automation products, with the majority of revenue derived from automation product sales from customer contracts. It operates in Canada, the United States, Europe, and Asia, with the majority of revenue coming from the United States.
27GF Score

Get the complete analysis for TELIF

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.53
Price
$0.38
GF Value